Cisen Pharmaceutical Co (SHSE:603367) 3-Year EBITDA Growth Rate : 12.50% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Cisen Pharmaceutical Co 3-Year EBITDA Growth Rate?

Cisen Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.36.

During the past 12 months, Cisen Pharmaceutical Co's average EBITDA Per Share Growth Rate was -9.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 3.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cisen Pharmaceutical Co was 24.00% per year. The lowest was -8.90% per year. And the median was 7.10% per year.

Competitive Comparison of Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Cisen Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cisen Pharmaceutical Co (SHSE:603367) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Cisen Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cisen Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cisen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cisen Pharmaceutical Co Ltd (SHSE:603367) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073

Website

http://www.lkcisen.com

Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.

Cisen Pharmaceutical Co Headlines

No Headlines